← Leaderboards
Xiaodi Felix Chen
Women And Infants Hospital-Rhode Island
$1,677,765
Attributed
$1,919,141
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $659.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,919,141 · 2
By mechanism
R01$1,436,388 · 1
R21$482,753 · 1
Top collaborators
- John Marshall2 shared
Most similar at Women And Infants Hospital-Rhode Island
Same institution · by research overlap
- Barbara S Stonestreet$5,440,794
Others in their field
Other Rising Stars on “Neurons”
- Sabrina Paganoni · Massachusetts General Hospital$15,344,018
- Suma Babu · Massachusetts General Hospital$15,344,018
- Thomas K Karikari · Wake Forest University Health Sciences$12,972,426
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
Research focus
NeuronsNeuroprotectionExposure ToMorris Water MazeNatural HypothermiaNeuroinflammationComplementDoseInjuryInflammatoryMotorBehavioral OutcomeAnti-Inflammatory AgentsNeonatal Hypoxic-Ischemic Brain InjuryCell DeathBirthApoptosisBrainBrain Hypoxia-IschemiaInfantAttenuatedBrain InjuriesBehavioralPathway Interactions
Grant awards (5)
Neuroprotective Strategy: Novel Purine Derivatives for Neonatal Hypoxia-ischemia$444,404
R01 · FY2025 · NS · contact PI
A Novel BDNF Potentiator for the Treatment of Neonatal Brain Injury$214,733
R21 · FY2025 · NS
A novel BDNF potentiator for the treatment of neonatal brain injury$268,020
R21 · FY2024 · NS
Neuroprotective Strategy: Novel Purine Derivatives for Neonatal Hypoxia-ischemia$495,992
R01 · FY2023 · NS · contact PI
Neuroprotective Strategy: Novel Purine Derivatives for Neonatal Hypoxia-ischemia$495,992
R01 · FY2022 · NS · contact PI